+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Carbapenems Drug Intermediates Market - Global Forecast 2026-2032- Product Image
Carbapenems Drug Intermediates Market - Global Forecast 2026-2032- Product Image
Sale

Carbapenems Drug Intermediates Market - Global Forecast 2026-2032

  • Report

  • 180 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6122217
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Carbapenems Drug Intermediates Market is projected to reach USD 814.27 Million in 2026. It is expected to continue growing at a CAGR of 14.79%, reaching USD 1.98 Billion by 2032.

Carbapenem Intermediate Supply Chains in a High-Scrutiny Market

Carbapenem drug intermediates are chemical building blocks used in the synthesis of carbapenem antibiotics. Their production is shaped by stringent quality requirements, controlled-substance handling considerations, complex multistep chemistry, and the need for reliable documentation across pharmaceutical supply chains. Executive attention is increasingly focused on continuity of supply, process consistency, environmental controls, and alignment with regulatory expectations in destination markets.

Regulatory, Resilience, and Sustainability Shifts Reshape Procurement

The landscape is shifting from cost-led sourcing toward a broader resilience model. Buyers are placing greater emphasis on qualified backup suppliers, traceability of critical raw materials, change-control discipline, and demonstrated manufacturing robustness. Regulatory scrutiny of impurities, residual solvents, elemental contaminants, and data integrity is encouraging tighter analytical controls. At the same time, solvent recovery, waste reduction, energy efficiency, and responsible chemical management are becoming more important in supplier qualification and long-term contracting.

Artificial Intelligence Strengthens Quality, Planning, and Process Control

Artificial intelligence can support this market by improving demand sensing, inventory prioritization, anomaly detection, and production scheduling. In manufacturing, machine-learning models may help identify process deviations earlier when they are combined with validated sensor data and established quality systems. AI can also accelerate document review, supplier-risk assessment, and investigation workflows. However, its use requires validated models, controlled data access, human oversight, cybersecurity safeguards, and clear accountability because automated outputs cannot replace pharmaceutical quality decisions.

Regional Differences Reflect Manufacturing Depth and Regulatory Maturity

North America emphasizes supply assurance, regulatory compliance, domestic resilience, and transparent qualification of pharmaceutical inputs. Latin America presents opportunities linked to local formulation and pharmaceutical manufacturing, while import dependence and differing regulatory capabilities can complicate sourcing. Europe places strong weight on environmental performance, pharmacopoeial quality, documentation, and supply-chain due diligence. The Middle East is advancing pharmaceutical localization in selected markets and requires dependable import, registration, and distribution pathways. Africa remains diverse, with access and infrastructure constraints influencing procurement reliability. Asia-Pacific combines substantial pharmaceutical-chemical manufacturing capacity with varied regulatory systems, making supplier auditing and cross-border compliance especially important.

Economic and Security Blocs Influence Qualification and Trade Practices

ASEAN economies are relevant to regional manufacturing and distribution networks, but regulatory coordination and technical capabilities vary across members. BRICS countries span major chemical, pharmaceutical, and industrial bases, creating opportunities for diversified sourcing alongside differences in quality systems and trade administration. The European Union provides a closely integrated regulatory and commercial environment with demanding standards for quality, environmental management, and documentation. G7 markets generally emphasize advanced compliance, supply resilience, and traceability. GCC countries are pursuing pharmaceutical and industrial diversification, while procurement is influenced by import logistics and localization goals. NATO members may give additional attention to continuity planning and strategic healthcare supply security, although requirements remain governed by national and regional authorities.

Country Priorities Range from Manufacturing Scale to Supply Security

Australia relies heavily on dependable international pharmaceutical supply chains and places importance on regulatory documentation and continuity planning. Brazil combines a large healthcare system with domestic manufacturing ambitions and complex regulatory and logistics considerations. Canada emphasizes dependable access, quality compliance, and coordination across an integrated North American supply network. China has extensive chemical and pharmaceutical manufacturing capabilities, with supplier qualification, environmental compliance, and export controls requiring careful assessment. France, Germany, Italy, and Spain operate within the European Union framework and prioritize validated quality systems, traceability, and sustainability. India is a major pharmaceutical manufacturing hub where process capability, regulatory readiness, and raw-material consistency are central procurement criteria. Japan and South Korea emphasize precision manufacturing, documentation, and advanced quality management. Mexico benefits from North American manufacturing linkages while requiring attention to customs, registration, and supplier oversight. Russia’s market access and sourcing environment are affected by trade restrictions and geopolitical conditions. The United Kingdom maintains rigorous pharmaceutical quality expectations and distinct post-EU regulatory processes. The United States places strong emphasis on current good manufacturing practice, supply-chain security, impurity control, and inspection readiness.

Prioritize Dual Sourcing, Validated Processes, and End-to-End Traceability

Industry leaders should establish risk-based qualification programs that assess technical capability, inspection history, financial resilience, environmental performance, and continuity plans. Dual sourcing should be pursued for strategically important intermediates where technically and economically feasible, with second sources qualified before disruption occurs. Contracts should define change notification, analytical comparability, audit rights, deviation handling, and data-retention expectations. Manufacturers should invest in process analytical technology, impurity monitoring, solvent-recovery programs, and secure digital records. AI initiatives should begin with narrowly defined, validated use cases and remain governed by quality, regulatory, and cybersecurity teams. Regional sourcing strategies should also account for customs exposure, geopolitical restrictions, transportation routes, and local registration requirements.

Methodology Combines Regulatory, Supply-Chain, and Manufacturing Evidence

This executive summary uses a structured qualitative assessment of the carbapenem drug-intermediates value chain. The approach considers intermediate chemistry, pharmaceutical manufacturing practices, regulatory expectations, quality risks, sustainability pressures, digitalization, trade conditions, and regional supply-chain characteristics. Geographic interpretation integrates North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific, alongside the specified economic and security groupings and countries. Findings are framed as strategic implications rather than quantitative market estimates and should be validated against current regulatory notices, supplier audits, pharmacopoeial requirements, customs conditions, and company-specific technical data.

Resilience and Compliance Define Competitive Readiness

The carbapenem drug-intermediates market is being shaped by the intersection of pharmaceutical quality, supply continuity, regulatory scrutiny, sustainability, and digital transformation. Organizations best positioned to respond will combine technically robust processes with transparent documentation, diversified sourcing, disciplined change control, and practical contingency planning. Artificial intelligence can reinforce these capabilities when deployed within validated quality systems. Across regions, groups, and countries, durable performance will depend less on isolated production advantages than on the ability to deliver consistent, traceable, compliant intermediates through an increasingly complex global supply chain.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Carbapenems Drug Intermediates Market, by Product Type
7.1. Introduction
7.2. Doripenem Intermediate
7.2.1. Biocatalysis
7.2.1.1. Early Stage
7.2.1.2. Late Stage
7.2.1.3. Mid Stage
7.2.2. Chemical Synthesis
7.2.2.1. Early Stage
7.2.2.2. Late Stage
7.2.2.3. Mid Stage
7.2.3. Fermentation
7.2.3.1. Early Stage
7.2.3.2. Late Stage
7.2.3.3. Mid Stage
7.3. Ertapenem Intermediate
7.3.1. Biocatalysis
7.3.1.1. Early Stage
7.3.1.2. Late Stage
7.3.1.3. Mid Stage
7.3.2. Chemical Synthesis
7.3.2.1. Early Stage
7.3.2.2. Late Stage
7.3.2.3. Mid Stage
7.3.3. Fermentation
7.3.3.1. Early Stage
7.3.3.2. Late Stage
7.3.3.3. Mid Stage
7.4. Imipenem Intermediate
7.4.1. Biocatalysis
7.4.1.1. Early Stage
7.4.1.2. Late Stage
7.4.1.3. Mid Stage
7.4.2. Biocatalysis
7.4.2.1. Early Stage
7.4.2.2. Late Stage
7.4.2.3. Mid Stage
7.4.3. Chemical Synthesis
7.4.3.1. Early Stage
7.4.3.2. Late Stage
7.4.3.3. Mid Stage
7.5. Meropenem Intermediate
7.5.1. Biocatalysis
7.5.1.1. Early Stage
7.5.1.2. Late Stage
7.5.1.3. Mid Stage
7.5.2. Chemical Synthesis
7.5.2.1. Early Stage
7.5.2.2. Late Stage
7.5.2.3. Mid Stage
7.5.3. Fermentation
7.5.3.1. Early Stage
7.5.3.2. Late Stage
7.5.3.3. Mid Stage
7.6. Panipenem Intermediate
7.6.1. Biocatalysis
7.6.1.1. Early Stage
7.6.1.2. Late Stage
7.6.1.3. Mid Stage
7.6.2. Chemical Synthesis
7.6.2.1. Early Stage
7.6.2.2. Late Stage
7.6.2.3. Mid Stage
7.6.3. Fermentation
7.6.3.1. Early Stage
7.6.3.2. Late Stage
7.6.3.3. Mid Stage
8. Carbapenems Drug Intermediates Market, by Process Type
8.1. Introduction
8.2. Biocatalysis
8.2.1. Early Stage
8.2.2. Late Stage
8.2.3. Mid Stage
8.3. Chemical Synthesis
8.3.1. Early Stage
8.3.2. Late Stage
8.3.3. Mid Stage
8.4. Fermentation
8.4.1. Early Stage
8.4.2. Late Stage
8.4.3. Mid Stage
9. Carbapenems Drug Intermediates Market, by Grade
9.1. Introduction
9.2. Pharmaceutical Grade
9.2.1. Doripenem Intermediate
9.2.2. Ertapenem Intermediate
9.2.3. Imipenem Intermediate
9.2.4. Meropenem Intermediate
9.2.5. Panipenem Intermediate
9.3. Technical Grade
9.3.1. Doripenem Intermediate
9.3.2. Ertapenem Intermediate
9.3.3. Imipenem Intermediate
9.3.4. Meropenem Intermediate
9.3.5. Panipenem Intermediate
10. Carbapenems Drug Intermediates Market, by Region
10.1. Introduction
10.2. Asia-Pacific
10.3. North America
10.4. Latin America
10.5. Europe
10.6. Middle East
10.7. Africa
11. Carbapenems Drug Intermediates Market, by Group
11.1. Introduction
11.2. ASEAN
11.3. GCC
11.4. European Union
11.5. BRICS
11.6. G7
11.7. NATO
12. Carbapenems Drug Intermediates Market, by Country
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. United Kingdom
12.7. Germany
12.8. France
12.9. Russia
12.10. Italy
12.11. Spain
12.12. China
12.13. India
12.14. Japan
12.15. Australia
12.16. South Korea
13. Competitive Landscape
13.1. Market Share Analysis, 2025
13.2. Market Concentration Analysis, 2025
13.2.1. Concentration Ratio (CR)
13.2.2. Herfindahl Hirschman Index (HHI)
13.3. Recent Developments & Impact Analysis, 2025
13.4. Product Portfolio Analysis, 2025
13.5. Benchmarking Analysis, 2025
14. Company Profiles
14.1. Bachem AG
14.2. Dr. Reddy's Laboratories Ltd.
14.3. Dr. Reddy’s Laboratories
14.4. Evonik Industries AG
14.5. Lonza Group AG
14.6. Lupin Limited
14.7. Merck KGaA
14.8. Shanghai United Medicine Co., Ltd.
14.9. Thermo Fisher Scientific Inc.
14.10. Wuhan Grand Hoyo Chemical Co., Ltd.
14.11. Wuxi AppTec Co., Ltd.
14.12. Zhejiang Jingxin Pharmaceutical Co., Ltd.
15. Key Experts
LIST OF FIGURES
FIGURE 1. Global Carbapenems Drug Intermediates Market, Years Considered for the Study
FIGURE 2. Global Carbapenems Drug Intermediates Market, Research Design
FIGURE 3. Global Carbapenems Drug Intermediates Market, Research Framework
FIGURE 4. Global Carbapenems Drug Intermediates Market, Data Triangulation
FIGURE 5. Global Carbapenems Drug Intermediates Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Carbapenems Drug Intermediates Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Carbapenems Drug Intermediates Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Carbapenems Drug Intermediates Market Size, by Process Type, 2025 vs 2032 (%)
FIGURE 9. Global Carbapenems Drug Intermediates Market Size, by Process Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Carbapenems Drug Intermediates Market Size, by Grade, 2025 vs 2032 (%)
FIGURE 11. Global Carbapenems Drug Intermediates Market Size, by Grade, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Carbapenems Drug Intermediates Market Size, by Region, 2025 vs 2032 (%)
FIGURE 13. Global Carbapenems Drug Intermediates Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Carbapenems Drug Intermediates Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 15. Global Carbapenems Drug Intermediates Market Size, by Country, 2025 vs 2032 (%)
FIGURE 16. Global Carbapenems Drug Intermediates Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Carbapenems Drug Intermediates Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Carbapenems Drug Intermediates Market Segmentation & Coverage
TABLE 2. Global Carbapenems Drug Intermediates Market Size, 2017-2032 (USD Million)
TABLE 3. Global Carbapenems Drug Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Doripenem Intermediate Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Doripenem Intermediate Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Doripenem Intermediate Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Biocatalysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Biocatalysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Biocatalysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Early Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Early Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Early Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Late Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Late Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Late Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Mid Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Mid Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Mid Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Chemical Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Chemical Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Chemical Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Early Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Early Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Early Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Late Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Late Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Late Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Mid Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Mid Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Mid Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Fermentation Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Fermentation Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Fermentation Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Early Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Early Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Early Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Late Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Late Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Late Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Mid Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Mid Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Mid Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Ertapenem Intermediate Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Ertapenem Intermediate Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Ertapenem Intermediate Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Biocatalysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Biocatalysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Biocatalysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Early Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Early Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Early Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Late Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Late Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Late Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Mid Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Mid Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Mid Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Chemical Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Chemical Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Chemical Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Early Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Early Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Early Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Late Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Late Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Late Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Mid Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Mid Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Mid Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Fermentation Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Fermentation Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Fermentation Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Early Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Early Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Early Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Late Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Late Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Late Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Mid Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Mid Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Mid Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Imipenem Intermediate Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Imipenem Intermediate Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Imipenem Intermediate Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Biocatalysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Biocatalysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Biocatalysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Early Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Early Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Early Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Late Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Late Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Late Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Mid Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Mid Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Mid Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Biocatalysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Biocatalysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Biocatalysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Early Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Early Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Early Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Late Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Late Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Late Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Mid Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Mid Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Mid Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Chemical Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Chemical Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Chemical Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Early Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Early Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Early Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Late Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Late Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Late Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Mid Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Mid Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Mid Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Meropenem Intermediate Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Global Meropenem Intermediate Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. Global Meropenem Intermediate Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. Global Biocatalysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Global Biocatalysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. Global Biocatalysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 127. Global Early Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Global Early Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. Global Early Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. Global Late Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Global Late Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. Global Late Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 133. Global Mid Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Global Mid Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. Global Mid Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 136. Global Chemical Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Global Chemical Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. Global Chemical Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 139. Global Early Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Global Early Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. Global Early Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. Global Late Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Global Late Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. Global Late Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. Global Mid Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Global Mid Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. Global Mid Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 148. Global Fermentation Market Size, by Region, 2017-2032 (USD Million)
TABLE 149. Global Fermentation Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. Global Fermentation Market Size, by Country, 2017-2032 (USD Million)
TABLE 151. Global Early Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. Global Early Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. Global Early Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 154. Global Late Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 155. Global Late Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. Global Late Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 157. Global Mid Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 158. Global Mid Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 159. Global Mid Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 160. Global Panipenem Intermediate Market Size, by Region, 2017-2032 (USD Million)
TABLE 161. Global Panipenem Intermediate Market Size, by Group, 2017-2032 (USD Million)
TABLE 162. Global Panipenem Intermediate Market Size, by Country, 2017-2032 (USD Million)
TABLE 163. Global Biocatalysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 164. Global Biocatalysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 165. Global Biocatalysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 166. Global Early Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 167. Global Early Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 168. Global Early Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 169. Global Late Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 170. Global Late Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 171. Global Late Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 172. Global Mid Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 173. Global Mid Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 174. Global Mid Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 175. Global Chemical Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 176. Global Chemical Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 177. Global Chemical Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 178. Global Early Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 179. Global Early Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 180. Global Early Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 181. Global Late Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 182. Global Late Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 183. Global Late Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 184. Global Mid Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 185. Global Mid Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 186. Global Mid Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 187. Global Fermentation Market Size, by Region, 2017-2032 (USD Million)
TABLE 188. Global Fermentation Market Size, by Group, 2017-2032 (USD Million)
TABLE 189. Global Fermentation Market Size, by Country, 2017-2032 (USD Million)
TABLE 190. Global Early Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 191. Global Early Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 192. Global Early Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 193. Global Late Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 194. Global Late Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 195. Global Late Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 196. Global Mid Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 197. Global Mid Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 198. Global Mid Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 199. Global Carbapenems Drug Intermediates Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 200. Global Biocatalysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 201. Global Biocatalysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 202. Global Biocatalysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 203. Global Early Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 204. Global Early Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 205. Global Early Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 206. Global Late Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 207. Global Late Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 208. Global Late Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 209. Global Mid Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 210. Global Mid Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 211. Global Mid Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 212. Global Chemical Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 213. Global Chemical Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 214. Global Chemical Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 215. Global Early Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 216. Global Early Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 217. Global Early Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 218. Global Late Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 219. Global Late Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 220. Global Late Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 221. Global Mid Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 222. Global Mid Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 223. Global Mid Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 224. Global Fermentation Market Size, by Region, 2017-2032 (USD Million)
TABLE 225. Global Fermentation Market Size, by Group, 2017-2032 (USD Million)
TABLE 226. Global Fermentation Market Size, by Country, 2017-2032 (USD Million)
TABLE 227. Global Early Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 228. Global Early Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 229. Global Early Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 230. Global Late Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 231. Global Late Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 232. Global Late Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 233. Global Mid Stage Market Size, by Region, 2017-2032 (USD Million)
TABLE 234. Global Mid Stage Market Size, by Group, 2017-2032 (USD Million)
TABLE 235. Global Mid Stage Market Size, by Country, 2017-2032 (USD Million)
TABLE 236. Global Carbapenems Drug Intermediates Market Size, by Grade, 2017-2032 (USD Million)
TABLE 237. Global Pharmaceutical Grade Market Size, by Region, 2017-2032 (USD Million)
TABLE 238. Global Pharmaceutical Grade Market Size, by Group, 2017-2032 (USD Million)
TABLE 239. Global Pharmaceutical Grade Market Size, by Country, 2017-2032 (USD Million)
TABLE 240. Global Doripenem Intermediate Market Size, by Region, 2017-2032 (USD Million)
TABLE 241. Global Doripenem Intermediate Market Size, by Group, 2017-2032 (USD Million)
TABLE 242. Global Doripenem Intermediate Market Size, by Country, 2017-2032 (USD Million)
TABLE 243. Global Ertapenem Intermediate Market Size, by Region, 2017-2032 (USD Million)
TABLE 244. Global Ertapenem Intermediate Market Size, by Group, 2017-2032 (USD Million)
TABLE 245. Global Ertapenem Intermediate Market Size, by Country, 2017-2032 (USD Million)
TABLE 246. Global Imipenem Intermediate Market Size, by Region, 2017-2032 (USD Million)
TABLE 247. Global Imipenem Intermediate Market Size, by Group, 2017-2032 (USD Million)
TABLE 248. Global Imipenem Intermediate Market Size, by Country, 2017-2032 (USD Million)
TABLE 249. Global Meropenem Intermediate Market Size, by Region, 2017-2032 (USD Million)
TABLE 250. Global Meropenem Intermediate Market Size, by Group, 2017-2032 (USD Million)
TABLE 251. Global Meropenem Intermediate Market Size, by Country, 2017-2032 (USD Million)
TABLE 252. Global Panipenem Intermediate Market Size, by Region, 2017-2032 (USD Million)
TABLE 253. Global Panipenem Intermediate Market Size, by Group, 2017-2032 (USD Million)
TABLE 254. Global Panipenem Intermediate Market Size, by Country, 2017-2032 (USD Million)
TABLE 255. Global Technical Grade Market Size, by Region, 2017-2032 (USD Million)
TABLE 256. Global Technical Grade Market Size, by Group, 2017-2032 (USD Million)
TABLE 257. Global Technical Grade Market Size, by Country, 2017-2032 (USD Million)
TABLE 258. Global Doripenem Intermediate Market Size, by Region, 2017-2032 (USD Million)
TABLE 259. Global Doripenem Intermediate Market Size, by Group, 2017-2032 (USD Million)
TABLE 260. Global Doripenem Intermediate Market Size, by Country, 2017-2032 (USD Million)
TABLE 261. Global Ertapenem Intermediate Market Size, by Region, 2017-2032 (USD Million)
TABLE 262. Global Ertapenem Intermediate Market Size, by Group, 2017-2032 (USD Million)
TABLE 263. Global Ertapenem Intermediate Market Size, by Country, 2017-2032 (USD Million)
TABLE 264. Global Imipenem Intermediate Market Size, by Region, 2017-2032 (USD Million)
TABLE 265. Global Imipenem Intermediate Market Size, by Group, 2017-2032 (USD Million)
TABLE 266. Global Imipenem Intermediate Market Size, by Country, 2017-2032 (USD Million)
TABLE 267. Global Meropenem Intermediate Market Size, by Region, 2017-2032 (USD Million)
TABLE 268. Global Meropenem Intermediate Market Size, by Group, 2017-2032 (USD Million)
TABLE 269. Global Meropenem Intermediate Market Size, by Country, 2017-2032 (USD Million)
TABLE 270. Global Panipenem Intermediate Market Size, by Region, 2017-2032 (USD Million)
TABLE 271. Global Panipenem Intermediate Market Size, by Group, 2017-2032 (USD Million)
TABLE 272. Global Panipenem Intermediate Market Size, by Country, 2017-2032 (USD Million)
TABLE 273. Global Carbapenems Drug Intermediates Market Size, by Region, 2017-2032 (USD Million)
TABLE 274. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Region, 2017-2032 (USD Million)
TABLE 275. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 276. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Doripenem Intermediate, 2017-2032 (USD Million)
TABLE 277. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Biocatalysis, 2017-2032 (USD Million)
TABLE 278. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 279. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Fermentation, 2017-2032 (USD Million)
TABLE 280. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Ertapenem Intermediate, 2017-2032 (USD Million)
TABLE 281. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Biocatalysis, 2017-2032 (USD Million)
TABLE 282. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 283. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Fermentation, 2017-2032 (USD Million)
TABLE 284. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Imipenem Intermediate, 2017-2032 (USD Million)
TABLE 285. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Biocatalysis, 2017-2032 (USD Million)
TABLE 286. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Biocatalysis, 2017-2032 (USD Million)
TABLE 287. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 288. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Meropenem Intermediate, 2017-2032 (USD Million)
TABLE 289. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Biocatalysis, 2017-2032 (USD Million)
TABLE 290. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 291. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Fermentation, 2017-2032 (USD Million)
TABLE 292. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Panipenem Intermediate, 2017-2032 (USD Million)
TABLE 293. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Biocatalysis, 2017-2032 (USD Million)
TABLE 294. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 295. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Fermentation, 2017-2032 (USD Million)
TABLE 296. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 297. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Biocatalysis, 2017-2032 (USD Million)
TABLE 298. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 299. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Fermentation, 2017-2032 (USD Million)
TABLE 300. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Grade, 2017-2032 (USD Million)
TABLE 301. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Pharmaceutical Grade, 2017-2032 (USD Million)
TABLE 302. Asia-Pacific Carbapenems Drug Intermediates Market Size, by Technical Grade, 2017-2032 (USD Million)
TABLE 303. North America Carbapenems Drug Intermediates Market Size, by Region, 2017-2032 (USD Million)
TABLE 304. North America Carbapenems Drug Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 305. North America Carbapenems Drug Intermediates Market Size, by Doripenem Intermediate, 2017-2032 (USD Million)
TABLE 306. North America Carbapenems Drug Intermediates Market Size, by Biocatalysis, 2017-2032 (USD Million)
TABLE 307. North America Carbapenems Drug Intermediates Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 308. North America Carbapenems Drug Intermediates Market Size, by Fermentation, 2017-2032 (USD Million)
TABLE 309. North America Carbapenems Drug Intermediates Market Size, by Ertapenem Intermediate, 2017-2032 (USD Million)
TABLE 310. North America Carbapenems Drug Intermediates Market Size, by Biocatalysis, 2017-2032 (USD Million)
TABLE 311. North America Carbapenems Drug Intermediates Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 312. North America Carbapenems Drug Intermediates Market Size, by Fermentation, 2017-2032 (USD Million)
TABLE 313. North America Carbapenems Drug Intermediates Market Size, by Imipenem Intermediate, 2017-2032 (USD Million)
TABLE 314. North America Carbapenems Drug Intermediates Market Size, by Biocatalysis, 2017-2032 (USD Million)
TABLE 315. North America Carbapenems Drug Intermediates Market Size, by Biocatalysis, 2017-2032 (USD Million)
TABLE 316. North America Carbapenems Drug Intermediates Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 317. North America Carbapenems Drug Intermediates Market Size, by Meropenem Intermediate, 2017-2032 (USD Million)
TABLE 318. North America Carbapenems Drug Intermediates Market Size, by Biocatalysis, 2017-2032 (USD Million)
TABLE 319. North America Carbapenems Drug Intermediates Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 320. North America Carbapenems Drug Intermediates Market Size, by Fermentation, 2017-2032 (USD Million)
TABLE 321. North America Carbapenems Drug Intermediates Market Size, by Panipenem Intermediate, 2017-2032 (USD Million)
TABLE 322. North America Carbapenems Drug Intermediates Market Size, by Biocatalysis, 2017-2032 (USD Million)
TABLE 323. North America Carbapenems Drug Intermediates Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 324. North America Carbapenems Drug Intermediates Market Size, by Fermentation, 2017-2032 (USD Million)
TABLE 325. North America Carbapenems Drug Intermediates Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 326. North America Carbapenems Drug Intermediates Market Size, by Biocatalysis, 2017-2032 (USD Million)
TABLE 327. North America Carbapenems Drug Intermediates Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 328. North America Carbapenems Drug Intermediates Market Size, by Fermentation, 2017-2032 (USD Million)
TABLE 329. North America Carbapenems Drug Intermediates Market Size, by Grade, 2017-2032 (USD Million)
TABLE 330. North America Carbapenems Drug Intermediates Market Size, by Pharmaceutical Grade, 2017-2032 (USD Million)
TABLE 331. North America Carbapenems Drug Intermediates Market Size, by Technical Grade, 2017-2032 (USD Million)
TABLE 332. Latin America Carbapenems Drug Intermediates Market Size, by Region, 2017-2032 (USD Million)
TABLE 333. Latin America Carbapenems Drug Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 334. Latin America Carbapenems Drug Intermediates Market Size, by Doripenem Intermediate, 2017-2032 (USD Million)
TABLE 335. Latin America Carbapenems Drug Intermediates Market Size, by Biocatalysis, 2017-2032 (USD Million)
TABLE 336. Latin America Carbapenems Drug Intermediates Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 337. Latin America Carbapenems Drug Intermediates Market Size, by Fermentation, 2017-2032 (USD Million)
TABLE 338. Latin America Carbapenems Drug Intermediates Market Size, by Ertapenem Intermediate, 2017-2032 (USD Million)
TABLE 339. Latin America Carbapenems Drug Intermediates Market Size, by Biocatalysis, 2017-2032 (USD Million)
TABLE 340. Latin America Carbapenems Drug Intermediates Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 341. Latin America Carbapenems Drug Intermediates Market Size, by Fermentation, 2017-2032 (USD Million)
TABLE 342. Latin America Carbapenems Drug Intermediates Market Size, by Imipenem Intermediate, 2017-2032 (USD Million)
TABLE 343. Latin America Carbapenems Drug Intermediates Market Size, by Biocatalysis, 2017-2032 (USD Million)
TABLE 344. Latin America Carbapenems Drug Intermediates Market Size, by Biocatalysis, 2017-2032 (USD Million)
TABLE 345. Latin America Carbapenems Drug Intermediates Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 346. Latin America Carbapenems Drug Intermediates Market Size, by Meropenem Intermediate, 2017-2032 (USD Million)
TABLE 347. Latin America Carbapenems Drug Intermediates Market Size, by Biocatalysis, 2017-2032 (USD Million)
TABLE 348. Latin America Carbapenems Drug Intermediates Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 349. Latin America Carbapenems Drug Intermediates Market Size, by Fermentation, 2017-2032 (USD Million)
TABLE 350. Latin America Carbapenems Drug Intermediates Market Size, by Panipenem Intermediate, 2017-2032 (USD Million)
TABLE 351. Latin America Carbapenems Drug Intermediates Market Size, by Biocatalysis, 2017-2032 (USD Million)
TABLE 352. Latin America Carbapenems Drug Intermediates Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 353. Latin America Carbapenems Drug Intermediates Market Size, by Fermentation, 2017-2032 (USD Million)
TABLE 354. Latin America Carbapenems Drug Intermediates Market Size, by Process Type, 2017-2032 (USD Million)
TABLE 355. Latin America Carbapenems Drug Intermediates Market Size, by Biocatalysis, 2017-2032 (USD Million)
TABLE 356. Latin America Carbapenems Drug Intermediates Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 357. Latin America Carbapenems Drug Intermediates Market Size, by Fermentation, 2017-2032 (USD Million)
TABLE 358. Latin America Carbapenems Drug Intermediates Market Size, by Grade, 2017-2032 (USD Million)
TABLE 359. Latin America Carbapenems Drug Intermediates Market Size, by Pharmaceutical Grade, 2017-2032 (USD Million)
TABLE 360. Latin America Carbapenems Drug Intermediates Market Size, by Technical Grade, 2017-2032 (USD Million)
TABLE 361. Europe Carbapenems Drug Intermediates Market Size, by Region, 2017-2032 (USD Million)
TABLE 362. Europe Carbapenems Drug Intermediates Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 363. Europe Carbapenems Drug Intermediates Market Size, by Doripenem Intermediate, 2017-2032 (USD Million)
TABLE 364. Europe Carbapenems Drug Intermediates Market Size, by Biocatalysis, 2017-2032 (USD Million)
TABLE 365. Europe Carbapenems Drug Intermediates Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 366. Europe Carbapenems Drug Intermediates Market Size, by Fermentation, 2017-2032 (USD Million)
TABLE 367. Europe Carbapenems Drug Intermediates Market Size, by Ertapenem Intermediate, 2017-2032 (USD Million)
TABLE 368. Europe Carbapenems Drug Intermediates Market Size, by Biocatalysis, 2017-2032 (USD Million)
TABLE 369. Europe Carbapenems Drug Intermediates Market Size, by Chemical Synthesis, 2017-2032 (USD Million)
TABLE 370. Europe Carbapenems Drug Intermediates Market Size, by Fermentation, 2017-2032 (USD Million)
TABLE 371. Europe Carbapenems Drug Intermediates Market Size, by Imipenem Intermediate, 2017-2032 (USD Million)

Companies Mentioned

  • Bachem AG
  • Dr. Reddy's Laboratories Ltd.
  • Dr. Reddy’s Laboratories
  • Evonik Industries AG
  • Lonza Group AG
  • Lupin Limited
  • Merck KGaA
  • Shanghai United Medicine Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • Wuhan Grand Hoyo Chemical Co., Ltd.
  • Wuxi AppTec Co., Ltd.
  • Zhejiang Jingxin Pharmaceutical Co., Ltd.

Related Topics

Related Reports

Pharmaceutical Intermediates Market - Global Forecast 2026-2032 - Product Image

Pharmaceutical Intermediates Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Penem Drug Intermediates Market - Global Forecast 2026-2032 - Product Image

Penem Drug Intermediates Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Pharmaceutical Grade Piperidine Derivatives Market - Global Forecast 2026-2032 - Product Image

Pharmaceutical Grade Piperidine Derivatives Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Pharmaceutical Chemicals - Global Strategic Business Report - Product Image

Pharmaceutical Chemicals - Global Strategic Business Report

  • Report
  • 285 Pages
  • Global
From
Sitolactone Market Analysis 2026-2031: Supply Chain Dynamics, Bio-fermentation Trends, and Production Capacities - Product Image

Sitolactone Market Analysis 2026-2031: Supply Chain Dynamics, Bio-fermentation Trends, and Production Capacities

  • Report
  • 83 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.